VRTX filings
Corporate insider profile
Mark E. Bunnage Filing Activity
Latest reported as EVP, Chief Scientific Officer of VERTEX PHARMACEUTICALS INC / MA (VRTX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$14,963.85
- Latest transaction
- May 15, 2026
Affiliated corporations
Reported company relationships
Transaction history
